to the one hundredth and one thousandth of a degree past the decimal diffractometers are incapable of accurate experimental determination beyond one tenth of a degree accordingly peak positions reported herein are rounded to one tenth of a degree past the decimal compositions made with or comprising a crystalline compound of this invention may be administered for example bucally ophthalmically orally osmotically parenterally intramuscularly intrasternally intravenously subcutaneously rectally topically transdermally or vaginally ophthalmically administered dosage forms may be administered as for example elixirs emulsions microemulsions ointments solutions suspensions or syrups orally administered solid dosage forms may be administered as for example capsules dragees emulsions granules pills powders solutions suspensions tablets microemulsions elixirs syrups or powders for reconstitution osmotically and topically administered dosage forms may be administered as for example creams gels inhalants lotions ointments pastes or powders parenterally administered dosage forms may be administered as for example aqueous or oleaginous suspensions rectally and vaginally dosage forms may be administered for example as creams gels lotions ointments or pastes the therapeutically acceptable amount of a crystalline compound of this invention depends on recipient of treatment disorder being treated and severity thereof composition containing it time of administration route of administration duration of treatment its potency its rate of clearance and whether or not another drug is co administered the amount of a crystalline compound of this invention used to make a composition to be administered daily to a patient in a single dose or in divided doses is from about 0 03 to about 200 mg kg body weight single dose compositions contain these amounts or a combination of submultiples thereof a crystalline compound of this.